menu
    • menu

    Company profile for STERIS Life Sciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    STERIS Corporation is a leading provider of infection prevention and surgical products and services, focused primarily on critical healthcare, pharmaceutical and research markets around the world. The Company supplies a broad array of equipment, consumable and service solutions that help assure productivity and quality. STERIS is listed on the New York Stock Exchange under the symbol STE.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    STERIS Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5960 Heisley Road Mentor, Ohio
    Telephone
    Telephone
    440-354-2600 + 800-444-9009
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sterislifesciences.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    STERIS Announces Financial Results For Fiscal 2026 Second Quarter
    STERIS Announces Financial Results For Fiscal 2026 Second Quarter

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3182019/0/en/STERIS-Announces-Financial-Results-for-Fiscal-2026-Second-Quarter.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    STERIS Announces Dividend Of $0.63 Per Share
    STERIS Announces Dividend Of $0.63 Per Share

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176907/0/en/STERIS-Announces-Dividend-of-0-63-per-share.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    STERIS To Host Fiscal 2026 Q2 Results Conference Call
    STERIS To Host Fiscal 2026 Q2 Results Conference Call

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170677/0/en/STERIS-to-Host-a-Conference-Call-for-Fiscal-2026-Second-Quarter-Results-on-November-6-2025.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Steris Announces Chief Financial Officer Transition
    Steris Announces Chief Financial Officer Transition

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128749/0/en/STERIS-Announces-Chief-Financial-Officer-Transition.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    STERIS Announces Financial Results for Fiscal 2026 First Quarter
    STERIS Announces Financial Results for Fiscal 2026 First Quarter

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128743/0/en/STERIS-Announces-Financial-Results-for-Fiscal-2026-First-Quarter.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    STERIS Increases Dividend to $0.63/Share
    STERIS Increases Dividend to $0.63/Share

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3124506/0/en/STERIS-Raises-Dividend-to-0-63-per-share.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact STERIS CORPORATION and get a quotation

    STERIS CORPORATION is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Olanzapine Pamoate bulk offered by STERIS CORPORATION

    Find a price of Rilpivirine bulk offered by STERIS CORPORATION

    Find a price of Triamcinolone Acetonide bulk offered by STERIS CORPORATION

    Find a price of Triptorelin Pamoate bulk offered by STERIS CORPORATION

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search